2010Zhongguo linchuang yaolixue yu zhiliaoxueRequires access

Bioequivalence of domperidone tablets in healthy male volunteers

Li Ling, Na Gao, Juan Gu, Yan Jin, Yang Guoping, Dongsheng Ouyang

Open publisher page 0 citations

Abstract

AIM:To evaluate the pharmacokinetics and bioequivalence of domperidone tablets in healthy volunteers.METHODS: A single dose(20 mg test or reference formation) was given to 18 healthy male volunteers according to an open randomized crossover design.The concentration of domperidone in plasma was determined by LC-MS.The pharmacokinetics parameters were calculated and the bioavailability and bioequivalence of two formulations were evaluated by DAS Ver 2.0.RESULTS: The main pharmacokinetic parameters of domperidone tablets were as follows: Cmax were(36±8) and(38±9) μg/L;tmax were(0.6±0.2) and(0.7±0.3) h;t1/2 were(10±8) and(9±3) h;AUC0-24 were(138±34) and(144±31) μg·L-1·h;AUC0-∞ were(168±68) and(166±37) μg·L-1·h.As assessed in accordance with AUC0-24,the relative bioavailability of two formulations was(97±20)%.CONCLUSION: The domperidone formulations are bioequivalent.

About this research paper

What this paper is about

AIM:To evaluate the pharmacokinetics and bioequivalence of domperidone tablets in healthy volunteers.METHODS: A single dose(20 mg test or reference formation) was given to 18 healthy male volunteers according to an open randomized crossover design.The concentration of domperidone in plasma was determined by LC-MS.The pharmacokinetics parameters were calculated and the bioavailability and bioequivalence of two formulations were evaluated by DAS Ver 2.0.RESULTS: The main pharmacokinetic parameters of domperidone tablets were as follows: Cmax were(36±8) and(38±9) μg/L;tmax were(0.6±0.2) and(0.7±0.3) h;t1/2 were(10±8) and(9±3) h;AUC0-24 were(138±34) and(144±31) μg·L-1·h;AUC0-∞ were(168±68) and(166±37) μg·L-1·h.As assessed in accordance with AUC0-24,the relative bioavailability of two formulations was(97±20)%.CONCLUSION: The domperidone formulations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM:To evaluate the pharmacokinetics and bioequivalence of domperidone tablets in healthy volunteers.METHODS: A single dose(20 mg test or reference formation) was given to 18 healthy male volunteers according to an open randomized crossover design.The concentration of domperidone in plasma was determined by LC-MS.The pharmacokinetics parameters were calculated and the bioavailability and bioequivalence of two formulations were evaluated by DAS Ver 2.0.RESULTS: The main pharmacokinetic parameters of domperidone tablets were as follows: Cmax were(36±8) and(38±9) μg/L;tmax were(0.6±0.2) and(0.7±0.3) h;t1/2 were(10±8) and(9±3) h;AUC0-24 were(138±34) and(144±31) μg·L-1·h;AUC0-∞ were(168±68) and(166±37) μg·L-1·h.As assessed in accordance with AUC0-24,the relative bioavailability of two formulations was(97±20)%.CONCLUSION: The domperidone formulations are bioequivalent.

Key concepts: Bioequivalence, Domperidone, Bioavailability, Pharmacokinetics, Cmax, Crossover study, Pharmacology, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of domperidone tablets in healthy male volunteers — Research Paper | ScholarLens